|Articles|January 1, 2016
WuXi Biologics
A full-service Contract Discovery, Development and Manufacturing Organization.
Advertisement
Your Trusted CDMO Solution
As a full-service Contract Discovery, Development and Manufacturing Organization, WuXi Biologics has manufactured material and provided CMC data for 40 global INDs in the past two years. With a team of 1200 highly-trained scientists under the leadership of industry recognized experts, we offer our clients the necessary expertise, quality and capacity to develop biologic drugs from concept to commercialization.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
How CDMO Alliances Can Provide End-to-End Service that Reduces Drug Development Time and Costs
2
First-in-Human Study Validates Safety of Next-Generation mRNA–LNP Platform
3
Industry Outlook 2026: Key Forces Transforming Drug Pipelines (Part 2)
4
FDA Clears PharmaResearch IND for Nano-Based Cancer Drug PRD-101
5